<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Kamynina E</dc:creator>
  <dc:creator>Debonneville C</dc:creator>
  <dc:creator>Bens M</dc:creator>
  <dc:creator>Vandewalle A</dc:creator>
  <dc:creator>Staub O</dc:creator>
  <dc:date>2001</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Liddle's syndrome is a form of inherited hypertension linked to mutations in the genes encoding the epithelial Na+ channel (ENaC). These mutations alter or delete PY motifs involved in protein-protein interactions with a ubiquitin-protein ligase, Nedd4. Here we show that Na+ transporting cells, derived from mouse cortical collecting duct, express two Nedd4 proteins with different structural organization and characteristics of ENaC regulation: 1) the classical Nedd4 (herein referred to as Nedd4-1) containing one amino-terminal C2, three WW, and one HECT-ubiquitin protein ligase domain and 2) a novel Nedd4 protein (Nedd4-2), homologous to Xenopus Nedd4 and comprising four WW, one HECT, yet lacking a C2 domain. Nedd4-2, but not Nedd4-1, inhibits ENaC activity when coexpressed in Xenopus oocytes and this property correlates with the ability to bind to ENaC, as only Nedd4-2 coimmunoprecipitates with ENaC. Furthermore, this interaction depends on the presence of at least one PY motif in the ENaC complex and on WW domains 3 and 4 in Nedd4-2. Thus, these results suggest that the novel suppressor protein Nedd4-2 is the regulator of ENaC and hence a potential susceptibility gene for arterial hypertension.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/139141</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1096/fj.00-0191com</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/11149908</dc:relation>
  <dc:source>FASEB journal : official publication of the Federation of American Societies for Experimental Biology. - 2001</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Amino Acid Motifs</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Amino Acid Sequence</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Binding Sites</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Calcium-Binding Proteins</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Cloning, Molecular</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Endosomal Sorting Complexes Required for Transport</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Ligases</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Mice</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Molecular Sequence Data</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Mutation</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Nedd4 Ubiquitin Protein Ligases</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Oocytes</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Protein Binding</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Protein Isoforms</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Protein Structure, Tertiary</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">RNA, Messenger</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Rats</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Sequence Alignment</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Sodium Channel Blockers</dc:subject>
  <dc:subject xmlns:ns21="xml" ns21:lang="en">Sodium Channels</dc:subject>
  <dc:subject xmlns:ns22="xml" ns22:lang="en">Ubiquitin-Protein Ligases</dc:subject>
  <dc:subject xmlns:ns23="xml" ns23:lang="en">Xenopus Proteins</dc:subject>
  <dc:subject xmlns:ns24="xml" ns24:lang="en">Xenopus laevis</dc:subject>
  <dc:title xmlns:ns25="xml" ns25:lang="en">A novel mouse Nedd4 protein suppresses the activity of the epithelial Na+ channel.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
